載入...
Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
A recent prospective clinical trial provides further evidence that breast cancers arising in germline BRCA1 mutation carriers are highly sensitive to cisplatin chemotherapy. The potential significance of these data for the management of patients with BRCA1-related and BRCA2-related breast cancer is...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053124/ https://ncbi.nlm.nih.gov/pubmed/23146216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3332 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|